Telemedicine Helped Ensure Essential Type 2 Diabetes Care Amid the COVID-19 Pandemic

A new study from the University of Eastern Finland indicates that the COVID-19 pandemic has seriously affected healthcare service usage among patients with 2 type diabetes in North Karelia, Finland, but essential care was continuously provided. The delivery of many essential services was facilitated by processes that strongly relied on telemedicine already before the pandemic.

The outbreak of COVID-19 has challenged healthcare systems and their ability to deliver essential health services. While social distancing measures avoided spreading the virus, they conflicted with good diabetes management, which requires regular follow-up visits to manage the disease and its complications.

In Finland, the government imposed a national lockdown on 16 March, lasting until mid-May 2020. This study used electronic health records to compare healthcare usage in the region of North Karelia in three different periods in 2020 - before, during, and after the lockdown - with the equivalent period in 2019.

In 2020, type 2 diabetes patients sought significantly fewer diabetes- and dental health-related primary healthcare services than the year before the pandemic, with the most significant reduction during the lockdown period. Emergency visits in specialized care dropped significantly during the lockdown period as well, but quickly recovered during the post-lockdown period, reaching the same volume as in 2019.

The high proportion of patients using remote services for diabetes management cushioned the drastic decline in face-to-face appointments - also among elderly patients aged 70 years or older. The proportion of remote consultation among all diabetes-related contacts increased from 56% before the pandemic to 88% during the lockdown period in 2020. Therefore, overall contacts were only 9% fewer in 2020 compared with 2019, while appointments halved.

"The pandemic has highlighted the importance of digital healthcare solutions," says Early Stage Researcher Laura Inglin from the University of Eastern Finland. "In Finland, patients have been able to receive new prescriptions, referrals for examinations, medical opinions, self-care instructions, and lifestyle guidance to monitor and control long-term diseases remotely already for some time. That was a great asset during the pandemic."

"Another asset of Finnish healthcare are high-quality electronic health records, which provide structured and up-to-date information about patients at the point of care. Using routine care data for research helps advance our collective knowledge of health system response to pandemics for future preparedness," Inglin points out.

Inglin L, Wikström K, Lamidi ML, Laatikainen T.
The adverse effect of the COVID-19 pandemic on health service usage among patients with type 2 diabetes in North Karelia, Finland.
BMC Health Serv Res. 2022 Jun 1;22(1):725. doi: 10.1186/s12913-022-08105-z

Most Popular Now

Study Finds One-Year Change on CT Scans …

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease...

New AI Tools Help Scientists Track How D…

Artificial intelligence (AI) can solve problems at remarkable speed, but it’s the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists...

Yousif's Story with Sectra and The …

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which...

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

New Antibiotic Targets IBD - and AI Pred…

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases...

Highland to Help Companies Seize 'N…

Health tech growth partner Highland has today revealed its new identity - reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and...